Jyong Biotech Ltd
MENS37.610USD
-1.130-2.92%
시장 운영 시간 （ET）시세는 15분 지연됩니다
2.86B시가총액
--P/E TTM
자세한 내용은 Jyong Biotech Ltd 회사
Jyong Biotech Ltd is a Taiwan-based science-driven biotechnology company. The Company is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The Company has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.
Jyong Biotech Ltd 정보
종목 코드 MENS
회사 이름Jyong Biotech Ltd
상장일Jun 17, 2025
CEOMr. Fu Feng Kuo
직원 수29
유형Ordinary Share
회계 연도 종료Jun 17
주소23F-3, No.95, Section 1, Xintai 5th, Xizhi District
도시NEW TAIPEI
증권 거래소NASDAQ Global Market Consolidated
국가Taiwan
우편 번호221
전화886227325205
웹사이트https://jyongbio.com/
종목 코드 MENS
상장일Jun 17, 2025
CEOMr. Fu Feng Kuo
Jyong Biotech Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Alfred Ying
Mr. Alfred Ying
Chief Financial Officer
Chief Financial Officer
4.00K
--
Dr. Fenglin Hsu
Dr. Fenglin Hsu
Director and Chief Technology Officer
Director and Chief Technology Officer
3.00K
--
Mr. Hung-Shu Fan
Mr. Hung-Shu Fan
Independent Director
Independent Director
--
--
Ms. Fu-Feng Kuo
Ms. Fu-Feng Kuo
Chairwoman of the Board and Chief Executive Officer
Chairwoman of the Board and Chief Executive Officer
--
--
Dr. Wanwen (Angela) Su
Dr. Wanwen (Angela) Su
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Pang-Chief Chi
Mr. Pang-Chief Chi
Independent Director
Independent Director
--
--
Mr. Ming Tsan Hsu
Mr. Ming Tsan Hsu
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Alfred Ying
Mr. Alfred Ying
Chief Financial Officer
Chief Financial Officer
4.00K
--
Dr. Fenglin Hsu
Dr. Fenglin Hsu
Director and Chief Technology Officer
Director and Chief Technology Officer
3.00K
--
Mr. Hung-Shu Fan
Mr. Hung-Shu Fan
Independent Director
Independent Director
--
--
Ms. Fu-Feng Kuo
Ms. Fu-Feng Kuo
Chairwoman of the Board and Chief Executive Officer
Chairwoman of the Board and Chief Executive Officer
--
--
Dr. Wanwen (Angela) Su
Dr. Wanwen (Angela) Su
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Pang-Chief Chi
Mr. Pang-Chief Chi
Independent Director
Independent Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Mon, Oct 27
마지막 업데이트: Mon, Oct 27
주주
주주 유형
주주
주주
비율
Perfect Minds Co Ltd
33.34%
Laxton Investments Company Ltd
10.04%
Linkage Gladden Enterprise Ltd
9.03%
Peak Valley International Co., Ltd.
6.71%
Honest Dynasty Ltd
3.08%
기타
37.80%
주주
주주
비율
Perfect Minds Co Ltd
33.34%
Laxton Investments Company Ltd
10.04%
Linkage Gladden Enterprise Ltd
9.03%
Peak Valley International Co., Ltd.
6.71%
Honest Dynasty Ltd
3.08%
기타
37.80%
주주 유형
주주
비율
Corporation
62.20%
Hedge Fund
0.09%
Investment Advisor/Hedge Fund
0.07%
Investment Advisor
0.03%
기타
37.61%
기관 주식 보유
마지막 업데이트: Wed, Jul 2
마지막 업데이트: Wed, Jul 2
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
5
148.54K
0.20%
+138.11K
2025Q2
7
47.29M
62.20%
+47.29M
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Perfect Minds Co Ltd
25.35M
33.34%
+25.35M
--
Jun 17, 2025
Laxton Investments Company Ltd
7.63M
10.04%
+7.63M
--
Jun 17, 2025
Linkage Gladden Enterprise Ltd
6.86M
9.03%
+6.86M
--
Jun 17, 2025
Peak Valley International Co., Ltd.
5.10M
6.71%
+5.10M
--
Jun 17, 2025
Honest Dynasty Ltd
2.34M
3.08%
+2.34M
--
Jun 17, 2025
Citadel Advisors LLC
70.97K
0.09%
+70.97K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
10.43K
0.01%
--
--
Aug 31, 2025
HRT Financial LP
22.92K
0.03%
+22.92K
--
Jun 30, 2025
Ying (Alfred)
4.00K
0.01%
+4.00K
--
Jun 17, 2025
Hsu (Fenglin)
3.00K
0%
+3.00K
--
Jun 17, 2025
더 보기
관련 ETF
마지막 업데이트: Thu, Nov 6
마지막 업데이트: Thu, Nov 6
이름
비율
Fidelity Nasdaq Composite Index ETF
0.01%
Fidelity Nasdaq Composite Index ETF
비율0.01%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
